Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ALLO)

CUSIP: 019770106

Q1 2026 13F Holders as of 31 Mar 2026

Security identity
Security type / class
Equity / Common Stock, par value $0.001 per share (the "Shares")
Shares outstanding
244,825,714
Holder snapshot
Total 13F shares
184,152,598
Share change
+21,717,638
Total reported value
$444,658,030
Put/Call ratio
44%
Reported price per share
$2.44
Number of holders
207
Value change
+$59,274,019
Number of buys
125
Number of sells
52

Security key

019770106

Report period

Q1 2026

Institutions

207

Top holders

10

ALLO full security history Ownership snapshot Full 13F holder table Previous quarter: Q4 2025 Allogene Therapeutics, Inc. SEC filings Allogene Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ALLO - Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
PFIZER INC
13D/G signal
PFIZER INC
Evidence rows
15
Latest as of
31 Mar 2026
13F 13D/G 3/4/5 Lead comparable stake: 9% 13D/G row: PFIZER INC Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
PFIZER INC
13F 13D/G
Company
13F 13D/G
9%
from 13D/G
$30,183,895
22,032,040 shares
 — 31 Dec 2025
Arie Belldegrun
13D/G 3/4/5
Arie Belldegrun, M.D. · Director
13D/G 3/4/5
5.4%
$32,857,975
13,466,383 shares
 +$532,440 31 Mar 2026
BlackRock, Inc.
13F 13D/G
Company
13F 13D/G
5.3%
from 13D/G
$24,216,160
17,676,029 shares
 — 31 Dec 2025
David D. Chang
13D/G 3/4/5
David D. Chang, M.D., Ph.D. · President and CEO, Director
13D/G 3/4/5
4.9%
$30,005,544
12,297,354 shares
 +$478,560 31 Mar 2026
FMR LLC
13D/G 13F
Company
13D/G 13F
4.9%
$15,747,811
10,225,851 shares
 -$20,861,062 28 Feb 2025
CITADEL ADVISORS LLC
13D/G 13F
Kenneth Griffin · Company
13D/G 13F
2.8%
$16,726,493
6,855,120 shares
 -$15,838,116 31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
207
Shares
184,152,598
Rows available
207
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
171
Q1 2026 holders
207
Holder diff
36
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .